Market Insight Drug Development |

Xphore For Extrahepatic Delivery Of RNAs

Covadonga Paneda

Chief Operating Officer

Altamira Therapeutics

12 August, 2026

Watch time: 23 Minutes

Highlights

Takeaways

• xPhore is a peptide based platform amenable to deliver most nucleic acid modalities, including siRNA, mRNA, circRNA and DNA

• xPhore delivers RNA/DNA to sites of inflammation without liver sequestration

• Modularity allows application in different indications

Covadonga Paneda, Chief Operating Officer, Altamira Therapeutics AG

PREMIUM CONTENT

Want that extra level of detail?
Subscribe and get access to full length presentations and write-ups giving you the insights to stay ahead of the curve.

Please note once we have received payment it can take 24 hours for your account to be updated to the premium access.

Upgrade

Full Video Transcript